0.307
price down icon3.58%   -0.0114
after-market Handel nachbörslich: .31 0.003 +0.98%
loading
Schlusskurs vom Vortag:
$0.3184
Offen:
$0.325
24-Stunden-Volumen:
2.91M
Relative Volume:
1.44
Marktkapitalisierung:
$8.00M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-16.26M
KGV:
-0.2599
EPS:
-1.1814
Netto-Cashflow:
$-13.50M
1W Leistung:
-7.81%
1M Leistung:
+10.83%
6M Leistung:
-87.96%
1J Leistung:
-93.68%
1-Tages-Spanne:
Value
$0.306
$0.325
1-Wochen-Bereich:
Value
$0.30
$0.3402
52-Wochen-Spanne:
Value
$0.2602
$4.9399

Intensity Therapeutics Inc Stock (INTS) Company Profile

Name
Firmenname
Intensity Therapeutics Inc
Name
Telefon
203-221-7381
Name
Adresse
1 ENTERPRISE DRIVE, SUITE 430, SHELTON
Name
Mitarbeiter
16
Name
Twitter
Name
Nächster Verdiensttermin
Name
Neueste SEC-Einreichungen
Name
INTS's Discussions on Twitter

Vergleichen Sie INTS mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Biotechnology icon
INTS
Intensity Therapeutics Inc
0.307 8.68M 0 -16.26M -13.50M -1.1814
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
470.13 119.21B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
560.93 59.16B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
325.28 40.57B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
571.23 34.02B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
295.59 29.19B 3.81B -644.79M -669.77M -6.24

Intensity Therapeutics Inc Aktie (INTS) Neueste Nachrichten

pulisher
Jul 22, 2025

What drives Intensity Therapeutics Inc. stock priceExtraordinary market timing - Autocar Professional

Jul 22, 2025
pulisher
Jul 22, 2025

Is Intensity Therapeutics Inc. a good long term investmentSky-high profits - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

How Intensity Therapeutics Inc. stock performs during market volatilityFree Membership Group - Newser

Jul 22, 2025
pulisher
Jul 22, 2025

What analysts say about Intensity Therapeutics Inc. stockFree Trading Psychology Coaching - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 21, 2025

The Business Case For Buying Intensity Therapeutics Inc (NASDAQ: INTS) Stock Now - Stocksregister

Jul 21, 2025
pulisher
Jul 19, 2025

Intensity Therapeutics Inc. Stock Analysis and ForecastOverwhelming profit margins - jammulinksnews.com

Jul 19, 2025
pulisher
Jul 19, 2025

SBXD.U Stock Analysis and ForecastFree Investment Case Studies - Jammu Links News

Jul 19, 2025
pulisher
Jul 18, 2025

Is EUDA a good long term investmentFree Investment Community - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

What drives World Kinect Corporation stock priceRapid portfolio appreciation - Jammu Links News

Jul 18, 2025
pulisher
Jul 18, 2025

Intensity Therapeutics shareholders elect director and approve auditor at annual meeting - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Intensity Therapeutics Holds Annual Stockholders’ Meeting - TipRanks

Jul 18, 2025
pulisher
Jul 18, 2025

Is AFJKU a good long term investmentDynamic investment growth - Jammu Links News

Jul 18, 2025
pulisher
Jul 17, 2025

why afloki(angryfloki) will explodeFree Access to Community - Newser

Jul 17, 2025
pulisher
Jul 15, 2025

How LGCL stock performs during market volatilityCapital Efficient Investment Tips - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why BNAIW stock attracts strong analyst attentionFree Investment Community - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How CAMP stock performs during market volatilityFree Smart Money Stock Analysis - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes AACT.WS stock price move sharplyFree Long-Term Wealth Growth Plan - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Mandatory Common Exchange Trust Preferred Security stock attracts strong analyst attention2x Return Forecast - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Intensity Therapeutics Inc. stock attracts strong analyst attentionDaily Price Surge List - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Capricor Therapeutics Inc. stock price move sharplyDaily Stock Radar - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes Intensity Therapeutics Inc. stock price move sharplySmart Money Signals - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why Herc Holdings Inc. stock attracts strong analyst attentionFree Real-Time Market Predictions - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Apple Hospitality REIT Inc. stock performs during market volatilityFree Group Entry - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

Why REXR.PRC stock attracts strong analyst attentionLong Term Safe Yield Focus - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How Ichor Holdings Ltd. stock performs during market volatilityHigh Accuracy Alerts - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

How LANDO stock performs during market volatilityTop Growth Low Risk Stocks - Newser

Jul 15, 2025
pulisher
Jul 15, 2025

What makes flyExclusive Inc. Equity Warrant stock price move sharplySafe and Smart Investment Picks - Newser

Jul 15, 2025
pulisher
Jul 14, 2025

INTS Stock: Exploring Intensity Therapeutics Inc’s Growth - investchronicle.com

Jul 14, 2025
pulisher
Jul 14, 2025

OP’s Market Quandary: Decoding the Ups and Downs of 2025 - investchronicle.com

Jul 14, 2025
pulisher
Jul 08, 2025

Intensity Therapeutics Inc’s Shares Reel: -85.34% Quarterly Revenue Decline Amid 7.38M Market Cap - investchronicle.com

Jul 08, 2025
pulisher
Jul 04, 2025

Intensity Therapeutics Announces $2.3 Million Public Offering of Common Stock - Global Legal Chronicle

Jul 04, 2025
pulisher
Jun 30, 2025

Oncology Innovation Just Hit a Turning Point — Here’s What to Watch - The Malaysian Reserve

Jun 30, 2025
pulisher
Jun 30, 2025

Oncology Innovation Just Hit a Turning Point -- Here's What to Watch - The Globe and Mail

Jun 30, 2025
pulisher
Jun 30, 2025

Intensity Therapeutics, Inc. Announces that INT230-6 Achieved 100% Complete Response Rate in Preclinical Models of Malignant Peripheral Nerve Sheath Tumors (MPNST) - Nasdaq

Jun 30, 2025
pulisher
Jun 28, 2025

INTS SEC FilingsINTENSITY THERAPEUTICS INC 10-K, 10-Q, 8-K Forms - Stock Titan

Jun 28, 2025
pulisher
Jun 20, 2025

With Public Funding Under Pressure, Biotech Innovators Are Picking Up the Slack in Oncology - PR Newswire UK

Jun 20, 2025
pulisher
Jun 17, 2025

Intensity Therapeutics, Inc. Announces the Closing and Full Exercise of the Over-Allotment Option from its Upsized Initial Public Offering, Raising a Total of $22.425 Million in Gross Proceeds - The Globe and Mail

Jun 17, 2025
pulisher
Jun 13, 2025

Why Is Intensity Therapeutics Stock (INTS) Down 50% Today? - The Globe and Mail

Jun 13, 2025

Finanzdaten der Intensity Therapeutics Inc-Aktie (INTS)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
$21.80
price up icon 0.51%
$36.10
price up icon 1.26%
$102.92
price up icon 0.14%
$26.54
price up icon 0.76%
$111.44
price up icon 2.32%
biotechnology ONC
$295.59
price up icon 1.25%
Kapitalisierung:     |  Volumen (24h):